The global sickle cell anemia testing and screening market size is poised for significant growth, with the market size expected to increase from USD 1.7 billion in 2025 to approximately USD 3.6 billion by 2033, expanding at a robust CAGR of 9.8% during the forecast period. This market encompasses a range of testing methods, including hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), point-of-care tests, and genetic testing, each playing a vital role in early detection an... moreThe global sickle cell anemia testing and screening market size is poised for significant growth, with the market size expected to increase from USD 1.7 billion in 2025 to approximately USD 3.6 billion by 2033, expanding at a robust CAGR of 9.8% during the forecast period. This market encompasses a range of testing methods, including hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), point-of-care tests, and genetic testing, each playing a vital role in early detection and management of sickle cell anemia, a genetic blood disorder characterized by abnormal hemoglobin production.
